At TCT 2025, Relief Cardiovascular, a company from the inQB8 incubator, won the Shark Tank innovation competition and its $200,000 award for its groundbreaking pressure- guided heart failure decongestion device . The system has also commencedits first-in-human feasibility study in Georgia. 

Peijia Medical established its partnership with the inQB8 incubator in June 2021. This strategic move granted Peijia full global rights to inQB8's TTVR technology and an equity stake in the incubator itself, providing access to its pipeline of future innovative projects.